273 related articles for article (PubMed ID: 17288528)
21. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
22. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity.
Zhang HJ; Yang JJ; Lu JP; Lai CJ; Sheng J; Li YX; Hao Q; Zhang SM; Gupta S
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):672-8. PubMed ID: 19296158
[TBL] [Abstract][Full Text] [Related]
23. [Synchronous multifocal osteogenic sarcoma].
Sulkes A; Biran H
Harefuah; 1981 Jan; 100(2):74-6. PubMed ID: 6943119
[No Abstract] [Full Text] [Related]
24. Osteosarcoma and other bone cancers.
Himelstein BP
Curr Opin Oncol; 1998 Jul; 10(4):326-33. PubMed ID: 9702400
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of bone malignancy in adolescence.
Caudill JS; Arndt CA
Adolesc Med State Art Rev; 2007 May; 18(1):62-78, ix. PubMed ID: 18605391
[TBL] [Abstract][Full Text] [Related]
26. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
27. Osteosarcoma.
Moore DD; Luu HH
Cancer Treat Res; 2014; 162():65-92. PubMed ID: 25070231
[TBL] [Abstract][Full Text] [Related]
28. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
Shang J; Bi ZG; Ji HF; Wang WB
Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
[TBL] [Abstract][Full Text] [Related]
29. Prognostic effects of doctor-associated diagnostic delays in osteosarcoma.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
Arch Orthop Trauma Surg; 2009 Oct; 129(10):1421-5. PubMed ID: 19280203
[TBL] [Abstract][Full Text] [Related]
30. Novel insights and therapeutic interventions for pediatric osteosarcoma.
Kager L; Tamamyan G; Bielack S
Future Oncol; 2017 Feb; 13(4):357-368. PubMed ID: 27651036
[TBL] [Abstract][Full Text] [Related]
31. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
Ek ET; Dass CR; Contreras KG; Choong PF
Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
[TBL] [Abstract][Full Text] [Related]
32. [Dissertations 25 years after the date 13. Sarcomas of the jaws].
Bras J
Ned Tijdschr Tandheelkd; 2007 Feb; 114(2):87-92. PubMed ID: 17361784
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?
Yamamoto N; Tsuchiya H
Expert Opin Pharmacother; 2013 Nov; 14(16):2183-93. PubMed ID: 23919484
[TBL] [Abstract][Full Text] [Related]
34. time dependency of prognostic factors in patients with stage II osteosarcomas.
Kim MS; Cho WH; Song WS; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Oct; 463():157-65. PubMed ID: 17621233
[TBL] [Abstract][Full Text] [Related]
35. [Interdisciplinary treatment of osteosarcomas].
Schultheiss M
Unfallchirurg; 2014 Jun; 117(6):490. PubMed ID: 24903498
[No Abstract] [Full Text] [Related]
36. Primary malignant bone tumors--a management approach.
Lange T; Garvin K; Jimenez J; Seibert J; Hutchins L; Hough A; Haynes D
J Ark Med Soc; 1985 Jul; 82(2):115-9. PubMed ID: 3161865
[No Abstract] [Full Text] [Related]
37. Osteosarcoma and other tumors of bone.
Mertens WC; Bramwell V
Curr Opin Oncol; 1995 Jul; 7(4):349-54. PubMed ID: 7578383
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.
Lamoureux F; Richard P; Wittrant Y; Battaglia S; Pilet P; Trichet V; Blanchard F; Gouin F; Pitard B; Heymann D; Redini F
Cancer Res; 2007 Aug; 67(15):7308-18. PubMed ID: 17671200
[TBL] [Abstract][Full Text] [Related]
39. Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.
Morrow JJ; Khanna C
Crit Rev Oncog; 2015; 20(3-4):173-97. PubMed ID: 26349415
[TBL] [Abstract][Full Text] [Related]
40. Bax gene therapy for human osteosarcoma using cationic liposomes in vivo.
Okumura K; Nakase M; Nakamura S; Kamei T; Inui M; Tagawa T
Oncol Rep; 2007 Apr; 17(4):769-73. PubMed ID: 17342313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
